Vivisol UK

What Vivisol UK does

Vivisol UK (legal entity: Dolby Medical Home Respiratory Care Ltd.) is a home respiratory care service provider operating across England and Scotland under NHS contracts. The company delivers five core service lines: home oxygen therapy (oxygen concentrators, static and ambulatory cylinders), sleep apnoea therapy (CPAP, BiPAP, and APAP devices with mask fitting and compliance monitoring), home non-invasive ventilation for patients with respiratory or neuromuscular insufficiency, aerosol/nebuliser therapy for chronic conditions such as COPD and cystic fibrosis, and emergency oxygen/AED services supplied to dental surgeries and GP practices. Equipment is sourced from multiple manufacturers including Philips Respironics, ResMed, Lowenstein, Fisher & Paykel, and BMC, allowing Vivisol to remain brand-agnostic and match devices to clinical need rather than being tied to a single vendor. Supporting infrastructure includes the Stirling oxygen filling plant, a 24/7 UK-based multilingual (11-language) contact centre, field technician home visits with urgent response capability as fast as four hours, the Viviopen clinician portal for HOOF Part A home oxygen prescribing, and the ViviAcademy eLearning platform.

The company is a wholly-owned subsidiary of the Vivisol Group, itself part of the Italian SOL Group, an industrial gases and home healthcare conglomerate. UK operations originated as Dolby Medical, founded in 1956 in Stirling by Ralph Dolby; following integration into the Vivisol family in 2010, the entity operated as Dolby Vivisol until adopting the Vivisol name in 2023. Vivisol UK serves an NHS patient base exceeding 30,000 across Scotland, South East England, South Central England, and North East England, with international patient reach across the broader Vivisol Group exceeding 800,000. Revenue is generated primarily through multi-year NHS managed service contracts covering equipment provision, installation, maintenance, consumables replenishment, and patient support, with secondary revenue from private-pay Vivitravel holiday oxygen services and commercial emergency oxygen equipment sales to healthcare facilities.

The go-to-market is predominantly enterprise sales to NHS trusts and clinicians through contractual relationships, supplemented by direct-to-consumer engagement via online reorder portals, 24/7 helplines, and home visits. Recent commercial expansion includes the February 2026 transition of the Norfolk and Norwich University Hospital (NNUH) Sleep and NIV service from Philips Healthcare to Vivisol, displacing a major incumbent and adding a new NHS trust to the customer base. The company holds ISO 27001 and Cyber Essentials certifications, has achieved a 20% reduction against its 2020 carbon baseline, and has committed to Net Zero emissions by 2035 under a board-approved Carbon Reduction Plan.

Name

Vivisol UK

Legal name

Dolby Medical Home Respiratory Care Ltd.

Website

https://vivisol.co.uk

Company type

Private

Founded year

1956

Operating status

Operating

Headcount range

101–250 employees

Short description

Vivisol UK is a home respiratory care service provider delivering home oxygen, sleep apnoea, ventilation, nebuliser, and emergency oxygen services to NHS patients across Scotland and parts of England, operating under multi-year NHS contracts and serving over 30,000 patients.

Ownership category

akta.pro rank

Product category

Home Respiratory Care Services

NAICS

Home Health Care Services (62161)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

akta.pro secondary industries

Home Respiratory & Ventilator Care (Skilled) (HLADAFAI), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC), Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG)

Keywords

• Home oxygen therapy
• Sleep apnoea treatment
• Home ventilation services
• Nebuliser therapy
• Emergency oxygen equipment

Headquarters

HQ city

Stirling

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. NHS Home Oxygen Service Contracts: Provision of home oxygen therapy, respiratory equipment, and related services to NHS patients free at point of delivery. Vivisol operates under NHS Scotland and NHS England contracts for home oxygen services across defined geographic regions.
2. NHS Respiratory Therapy Services: Home ventilation therapy, sleep apnoea therapy, and aerosol/nebuliser therapy services provided under NHS contracts to healthcare organizations.
3. Vivitravel Holiday Oxygen (Private Pay): Private oxygen therapy for patients traveling within the UK. Services include equipment access, 24-7 support contact centre, and holiday enquiry handling. Payment required in advance.
4. Emergency Oxygen Service (Commercial): Sale and maintenance of emergency oxygen equipment and airway management kits to healthcare settings including dental surgeries, GP practices, and healthcare facilities.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Vivisol UK provides home respiratory care services to NHS and private patients across England and Scotland, delivering home oxygen therapy, sleep apnoea therapy (CPAP/BiPAP), home non-invasive ventilation, aerosol/nebuliser therapy, and emergency oxygen equipment to clinical settings. Services include equipment installation, maintenance, consumables replenishment, 24/7 helpline support, and clinical engagement with NHS trusts under multi-year regional contracts.

Product overview

Vivisol UK is a home healthcare service provider offering a portfolio of respiratory care products and services primarily to NHS and private patients across England and Scotland. The core offering is built around five service pillars: Home Oxygen Therapy (oxygen concentrators, static and ambulatory cylinders), Sleep Apnoea Therapy (CPAP/BiPAP/APAP devices, masks, and compliance apps including prisma APP and BMC PAP App), Home Ventilation Therapy (NIV services), Aerosol/Nebuliser Therapy, and Emergency Oxygen/AED services. Supporting these are add-on modules including Vivitravel (oxygen provision for UK holidaymakers), Airway Management Kits, the STOPBANG questionnaire tool, and the Viviopen portal for clinicians to submit HOOF Part A forms. The company operates as a sub-brand of the European Vivisol group (SOL Group) and maintains regional offices in Stirling and Crawley, with multilingual contact centre support.

Differentiator

Problem solved

Functional benefit

Products and services

• Home Oxygen Therapy Provides home oxygen therapy services to NHS and private patients across England and Scotland, including installation and maintenance of oxygen concentrators, static cylinders, and ambulatory cylinders, with 24/7 helpline support.
• Sleep Apnoea Therapy Provides diagnosis and treatment for sleep-disordered breathing through home-based cardio-respiratory diagnostic systems and CPAP/BiPAP/APAP devices, supporting patients with mask fitting, compliance monitoring, and ongoing equipment maintenance.
• Home Ventilation Therapy Provides Home NIV (Non-Invasive Ventilation) services for patients with insufficient respiratory effort due to disorders of the respiratory, nervous, or musculoskeletal systems, including equipment provision, installation, and patient/carer training.
• Aerosol / Nebuliser Therapy Provides integrated nebuliser therapy for treating chronic respiratory conditions such as asthma, COPD, cystic fibrosis, and pulmonary hypertension, including professional nebuliser equipment installation, patient education, and consumables replenishment.
• Emergency Oxygen Service Provides emergency oxygen resuscitation equipment (2-litre and 10-litre cylinders) and AED services for clinical settings such as dental surgeries and GP practices, meeting Resuscitation Council UK guidelines, with annual servicing and cylinder refills.
• Vivitravel Arranges private oxygen therapy for patients travelling within the UK (South East England and Scotland) and coordinates international travel oxygen supply through third-party providers, including a dedicated holiday enquiry line and 24/7 support.
• Adult and Paediatric Airway Management Kits Emergency oxygen kits containing BVM (reservoir bag ventilation masks), Guedel airways, and oxygen masks for adult and paediatric patients, sold as part of the Emergency Oxygen Service product range.

Quantifiable outcome

• 20% carbon emission reduction against 2020 baseline (301.6 tCO2e saved)
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• NHS GrampiancoreStrategic or Co-development Partner · 16 April 2026Clinical engagement partnership involving site visits to Stirling Oxygen Filling Plant. Eight clinicians from NHS Grampian participated in comprehensive overview of Scottish Home Oxygen Service, strengthening clinical partnerships and collaboration.
• Norfolk and Norwich University Hospital (NNUH)coreStrategic or Co-development Partner · 23 February 2026Service transition partnership where Vivisol took over as Sleep and NIV supplier from Philips Healthcare. Vivisol responsible for managing equipment, troubleshooting CPAP/NIV devices, annual mask/interface replacements, and compliance monitoring.
• NHS Scotland / National Services ScotlandcoreStrategic or Co-development PartnerPrimary NHS contract partner for Scottish Home Oxygen Service. NHS Scotland works with Vivisol for home oxygen provision across Scotland, including through Health Facilities Scotland partnership. Vivisol recognised alongside NSS for COVID-19 oxygen service contributions.
• SOL Group (Italy)coreOthersSOL Group is the parent company of Vivisol. Vivisol was founded as an arm of SOL Group in 1986, dedicated to Home Respiratory Care. SOL Group provides strategic direction and support across the Vivisol family of companies. SOL Feluy (Belgium) provides tanker deliveries for oxygen supply.
• Vivisol Group (Europe)coreOthersVivisol is part of the Vivisol Group, a European leader in home respiratory care with operations across Europe. The UK entity (formerly Dolby Vivisol) became fully aligned with the Vivisol family in 2023.
• Oxygen WorldwideminorChannel Partner/ Reseller/ DistributorThird-party oxygen provider referenced for international travel oxygen arrangements. Patients traveling abroad are directed to Oxygen Worldwide for oxygen supply outside Vivisol's UK service regions.
• Pure O2 and The Oxygen StoreminorChannel Partner/ Reseller/ DistributorAlternative oxygen providers listed for patients requiring oxygen abroad. Vivisol directs patients to these companies for international travel arrangements.
• British Lung FoundationminorGTM or Marketing PartnerPartnership for travel insurance advice. British Lung Foundation provides resources and support for people affected by lung conditions to find affordable travel insurance.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Philips Respironics: Sleep and respiratory device manufacturer whose UK hospital-based services Vivisol displaced at NNUH in Feb 2026. Direct equipment and service-line overlap; Philips recall and subsequent industry service-insourcing opportunity is the basis of Vivisol's NNUH win.
• Linde Healthcare: Global industrial gases company's healthcare division offering home oxygen, sleep and respiratory services across multiple UK regions. Major incumbent competitor with broader portfolio and geographic reach than Vivisol UK.
• Apria Healthcare: Large US-headquartered home medical equipment provider offering home oxygen, sleep therapy and ventilation services. International analogue in scale and multi-product home respiratory delivery model, useful as a peer benchmark for portfolio breadth and operating leverage.
• ResMed: Global sleep apnoea and respiratory care leader whose CPAP/BiPAP devices (AirSense 10, AirFit) Vivisol supports and whose myair app complements the patient engagement stack. Overlaps with Vivisol in sleep therapy delivery and connected-care monitoring.
• Air Liquide Healthcare: UK arm of global gas major Air Liquide providing home respiratory care, oxygen therapy and chronic disease home management. Significantly larger and broader than Vivisol UK, with overlapping NHS and private home oxygen services.

Others

• SOL Group (parent): Italian parent conglomerate of Vivisol Group, providing medical and industrial gases, home healthcare and specialty chemicals. Relevant as parent/ecosystem player enabling Vivisol UK's oxygen supply (via SOL Feluy tanker deliveries) and shared group capabilities.
• Fisher & Paykel Healthcare: New Zealand-based manufacturer of CPAP, humidification and respiratory care devices (Sleepstyle range) supplied and supported by Vivisol UK. Adjacent ecosystem peer rather than a competitor, but comparable in category and shared commercial linkage.

Direct peers

• BOC Healthcare (Linde): UK arm of the Linde Group providing home oxygen therapy, medical gases and respiratory services to NHS patients. Direct competitor in the NHS Home Oxygen Service framework and a major incumbent in regions where Vivisol does not operate.
• Baywater Healthcare: UK-headquartered independent home oxygen and respiratory therapy provider directly competing with Vivisol for NHS Home Oxygen Service contracts across English regions. Closest direct peer in patient base, service model and NHS contracting.

Regional players

• Medigas (Sapio Group): Italian home respiratory care provider, comparable European-headquartered peer offering oxygen, sleep and ventilation services in a different geography (primarily Italy). Sister-analogue to Vivisol within the SOL/Sapio universe of European home-respiratory operators.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/DolbyVivisol
• LinkedInlinkedin.com/company/vivisol-uk

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivisol UK